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Abstract
Background: Sec63 is a key component of the protein translocation machinery in the mammalian
endoplasmic reticulum (ER), and involved in the post-translation processing of secretory proteins.
The aim of this study was to determine the expression pattern of SEC63 gene in mouse uterus
during the early pregnancy.
Methods: Real-time quantitative PCR and Western blot analyses were used to evaluate the
alteration in levels of uterine SEC63 gene expression during the peri-implantation period in mice.
Further, both in situ hybridization and immunohistochemical analyses were performed to examine
the spatial localization of SEC63 gene expression in mouse uterine tissues. The presence of Sec63
protein in human uterine tissue was also detected by immunohistochemical analysis. Statistical
analysis was carried out using Tukey test.
Results: Uterine SEC63 gene expression was up-regulated and predominantly localized in mouse
decidual cells during days 5–8 of pregnancy. More interestingly, Sec63 protein was also detected in
human decidua of 10-week pregnancy, whereas was not observed in human endometrial tissues
both at proliferative and secretory phases of menstrual cycle.
Conclusion: The pattern of SEC63 gene expression is consistent with a possible role for SEC63
in decidualization.
Background
Embryo implantation is a critical step in pregnancy and
currently considered the most relevant limiting factor for
successful pregnancy [1,2]. Successful implantation
depends on the synchronized development of a normal
embryo to the blastocyst stage, and the maternal uterus
from a non-receptive to a receptive state, as well as the
establishment of the active interactions between maternal
and embryonic tissues [3,4]. This exquisite coordination
involves the regulated production of hormonal and non-
hormonal molecules by embryonic and maternal tissues
[5,6]. A large number of non-hormonal factors have been
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identified to be involved in this process, and some of
them have been extensively investigated and regarded as
the endometrial receptivity markers [4,7]. However, the
exact molecular interactions between the implanting
embryo and the maternal uterus are still not clear. To
identify novel genes that could be crucial for embryo
implantation and to explore their biological roles in
implantation would undoubtedly accelerate a better
insight into the molecular mechanism underlying embryo
implantation.
In order to search for the novel molecules that are highly
expressed at the implantation sites, we have successfully
applied the CLONTECH PCR-select cDNA subtraction
technique to screen specifically up-regulated genes in the
mouse uterus around the time of implantation [8,9]. One
of the genes screened out from the subtracted cDNA
library was SEC63  gene that encodes Sec63 protein
(Sec63p). Sec63p is involved in the post-translational
processing of secretory proteins [10], including the fold-
ing and quality control of secretory proteins [11,12], as a
component of the protein translocation machinery in the
endoplasmic reticulum (ER) of eukaryotic cells [13,14].
SEC63 expression was originally found in Saccharomyces
cerevisiae [15]. The mammalian SEC63 cDNA and Sec63p
were also identified subsequently [16]. Mammalian
Sec63p consists of 760 amino acids, sharing 53% homol-
ogy and 25.6% identity with the yeast Sec63p [16]. As an
ER integral membrane protein of the Hsp40 family
[17,18], Sec63p could facilitate protein translocation into
the ER. The C-terminal conserved Brr2-like domain of
Sec63p, that could be phosphorylated by the protein
kinase CK2, is essential for its function [18,19]. Sec63p is
required for post-translational translocation of invertase,
carboxypeptidase Y (CPY) and dipeptidyl-aminopepti-
dase B (DPAP B) in yeast [15,20,21]. In mammals, Sec63p
is a prime candidate for co-chaperone of IgG heavy chain-
binding protein (BiP/Kar2p) in protein transport [22].
However, the exact secretory protein species of Sec63p-
dependent secretion in mammals is still unclear. Because
mammalian uteri synthesize secretory proteins essential
for survival and development of the embryo and fetus
during pregnancy [23], we hypothesize that Sec63p may
also be involved in the process of embryo implantation.
Thus, the present study was undertaken to examine the
pattern of SEC63 gene expression in the uterus during the
peri-implantation period in mice by in situ hybridization
and immunohistochemistry.
Methods
Animals and tissue preparation
Adult ICR mice aged 6–8 weeks were obtained from the
SIPPR/BK Laboratory Animal Company (Shanghai,
China). All of the mice were caged at controlled tempera-
ture (approximately 22°C) under a 14 h light: 10 h dark
photoperiod. All the experiments were in full compliance
with standard laboratory animal care protocols (NTC-
SOP-ADM-ANM-003, -014, -038, -039 and -040)
approved by the Institutional Animal Care Committee of
Shanghai Institute of Planned Parenthood Research.
Adult females were mated with fertile males of the same
strain to achieve pregnancy (day1 = day of vaginal plug).
Pregnancy was confirmed on days 1–4 by recovering
embryos from the reproductive tracts. The implantation
sites on days 5–6 were identified by intravenous injection
of Chicago blue dye solution (1% in saline; 0.1 ml per
mouse; Sigma, St Louis, MO). The entire uteri of non-
pregnant and pregnant mice on days 1–4 pregnancy were
respectively collected immediately after the mice were sac-
rificed by cervical dislocation. For days 5–8 of pregnancy,
uterine tissues at implantation sites and inter-implanta-
tion sites were separately collected. Embryos were col-
lected by flushing the uterus with PBS at 07:00–08:00 on
day 5 of pregnancy.
Pseudopregnant mice were obtained by mating females
with vasectomized males, and the entire uteri of pseudo-
pregnant mice on days 1–5 were collected. Implantation
was delayed by ovariectomizing pregnant mice at 08:30–
09:00 h on day 4 of pregnancy and administering proges-
terone (1 mg per mouse, Sigma) during days 5–7. Delayed
implantation was subsequently initiated by administering
estradiol-17β (25 ng per mouse, Sigma) on day 7. The
uterine tissues were respectively collected at 24 h after
estrogen or last progesterone treatment. Delayed implan-
tation was confirmed by flushing the blastocysts from
uterus, and the activation of delayed implantation was
identified by intravenous injection of Chicago blue dye
solution [8,9].
Ovary and non-reproductive tissues including brain, lung,
heart, liver, spleen, kidney, muscle, small intestine, skin
were also collected from the day 5 pregnant mouse. Male
reproductive tissues, testis and epididymis, were collected
from adult male mice. All tissues collected were stored at
-80°C until further analysis.
The sections of human decidual and oviductal tissues
were kindly provided by the International Peace Maternity
and Child Healthcare Hospital, the China Welfare Insti-
tute, Shanghai, China. Ethical approvals were granted
both from Shanghai Institute of Planned Parenthood
Research, and the Department of Obstetrics and Gynecol-
ogy, Shanghai Jiao Tong University. All subjects signed an
informed consent before the collection of decidual and
oviductal tissues.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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Reverse transcription (RT)-PCR
Different tissues, including brain, lung, heart, liver,
spleen, kidney, muscle, small intestine, skin, ovary,
uterus, testis and epididymis, were individually collected
from 3 mice and pooled. Total RNA was then respectively
extracted from each tissue pool using Trizol reagent (Inv-
itrogen Life Technologies Ltd, Renfrew, Strathclyde, UK),
and the RNA quality was evaluated by the ratio of optical
density (OD260: OD280). Only these RNA samples with a
ratio > 1.8 were used for PCR. Each RNA sample (2 μg)
was treated by RNase-free DNase I (TakaRa Biotechnology
Co.) at 37°C for 30 min. RNA Reverse transcription (RT)
was performed at 42°C for 1 h with the poly(dT) primer
in 50 μl reaction mixture using Superscript MII reverse
transcriptase (Gibco BRL, Invitrogen Corporation,
Carlsbad, CA) according to the manufacturer's instruc-
tions. Then, 2 μl RT reaction mixture were used as the tem-
plate for PCR amplification at the cycling conditions:
94°C 20 sec, 57°C 20 sec, 72°C 30 sec for 35 cycles. The
primers used to detect the targeted and housekeeping con-
trol mRNAs were as follows: SEC63, 5'-AAGAATGAAC-
CTCCACTCACC-3' (sense) and 5'-
GTCCTCTTCAATATGAGGGAGC-3' (antisense) (318 bp);
GAPDH, 5'-GTCGGTGTGAACGGATTT-3' (sense) and 5'-
ACTCCACGACATACTCAGC-3' (antisense) (276 bp).
PCR products were separated on 2% agarose gel and
stained with ethidium bromide (EB), and the signal was
photographed by BioSens Gel Imaging System (Shanghai
Bio-Tech Co., Ltd., Shanghai, China). The RT-PCR reac-
tion conditions were optimized, specific product was
obtained and verified by sequencing.
Real-time quantitative PCR analysis
Uterine expression levels of SEC63 mRNA on days 4, 5
and 7, as well as the inter-implantation sites and implan-
tation sites of day 7 pregnant mice, were relatively deter-
mined by real-time quantitative PCR analysis using the
level of β-Actin mRNA as the reference. Uterine tissues
were collected from 3 mice at each time-point and pooled.
Total RNA samples were isolated and RT reactions were
performed as above described. The primers were as fol-
lows: SEC63, 5'-TGACAAGGGCAGTGATTCTG-3' (sense)
and 5'-GCCACCACC ACTCTTGTTTT-3' (antisense) (248
bp);  β-Actin, 5'-AGCCATGTACGTAGCCATCC-3'(sense)
and 5' CTCTCAGCTGTGGTGGTGAA-3' (antisense) (228
bp). All amplifications were designed to span over introns
to rule out the genomic DNA contamination, and the PCR
products were authenticated by sequencing. The PCR reac-
tion mixture (25 μl) contained 12.5 μl SYBR green I reac-
tion (QPK-201, Toyobo Co., Ltd., Osaka, Japan). The
reactions were performed on the Peltier Thermal Cycler
(Bio-Rad Laboratories, Hercules, CA) at the conditions:
94°C 15 sec, 55°C 30 sec, 72°C 45 sec for 46 cycles. The
RT-PCR conditions were optimized and the melting curve
presents a single amplified band. The Ct data were
imported into Microsoft Excel, the relative value of Sec63
mRNA copies was obtained according to 2-ΔΔCt method
[24]. Triplicate PCR reactions were run simultaneously,
and the mean of measured values was used to get the ratio
between SEC63 mRNA and β-Actin mRNA, to represent
the relative expression level of SEC63 mRNA. The data
from 3 independent experiments (triplicate of the pooled
data, from a total of 9 mice) were taken for statistical treat-
ments.
Western blot analysis
Following a described protocol [25], samples of total pro-
teins were isolated respectively from the mouse uterine
tissues on days 1 to 7 of pregnancy, separated on the
sodium dodecyl sulfate (SDS) polyacrylamide gel electro-
phoresis (100 μg proteins per well), and transferred to a
nitrocellulose membrane (Hybond™-C, Amersham Bio-
sciences, Piscataway, NJ). The membrane was washed sev-
eral times with 10% skim milk powder in TBS with 0.1%
Tween-20 (Sigma, St. Louis, MO, USA) and incubated
with the goat anti-sera specific for both mouse and human
Sec63p (1:50, Santa Cruz Biotechnology Inc, Santa Cruz,
C A )  i n  b l o c k i n g  s o l u t i o n  ( 7  m M  N a 2HPO4, 2.5 mM
NaH2PO4, 140 mM NaCl, 4.5% skim milk powder) for 2
h. Then the membrane was washed and incubated with
alkaline phosphatase-labeled secondary antibodies
(ZYMED, S. San Francisco, CA) in blocking solution for 2
hrs at room temperature. After further washing, the signal
was visualized with BCIP/NBT (ZYMED) in 0.1 M
Tris·HCl (pH 9.5) and 4 mM MgCl2. Comparable protein
loading per lane was confirmed by using β-actin as the ref-
erence. The rabbit anti-β-actin antibody (Abcam, Cam-
brige, UK) was used as the primary antibody, and the AP-
labeled donkey antibody against rabbit IgG (ZYMED) was
used as the secondary antibody. Normal goat IgG was
used as the primary antibody in parallel to check the
immunological specificity.
In situ hybridization
A 450 bp (C65 – G514) SEC63 cDNA fragment (Accession
no. AY024346) was obtained by restriction digestion of
the plasmid pMD18-T/SEC63 using Nco I and Nde I. The
plasmid contained the full length 2558 bp SEC63 cDNA,
kindly provided by Professor Cheng-quan Liu, Shanghai
Institute of Planned Parenthood Research. The SEC63
cDNA fragment (SEC63f) was subcloned into the pGEM-
T at Nco I and Nde I restruction sites. Then the recom-
binant plasmid pGEM-T/SEC63f was linearized for labe-
ling. Digoxigenin (DIG)-labeled antisense or sense cRNA
probes were transcribed in vitro using a DIG RNA labeling
kit (Roche Diagnostics Corp., Indianapolis, IN).
Uteri were cut into 4–6 mm pieces and flash frozen in liq-
uid nitrogen. Frozen sections (10 μm) were mounted on
3-aminopropyltriethoxy-silane-coated (Sigma, St Louis,Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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MO) slides and fixed in 4% (w/v) paraformaldehyde solu-
tion in PBS. The sections were washed twice in PBS, placed
in 1% (v/v) Trition-X100 for 20 min and washed again in
PBS three times. After the pre-hybridization in the solu-
tion of 50% formamide and 5 × SSC (1 × SSC is 0.15 M
sodium chloride, 0.015 M sodium citrate) at room tem-
perature for 15 min, the sections were hybridized in the
hybridization buffer (5 × SSC, 50% formamide, 0.02%
BSA, 250 μg yeast tRNA ml-1, 10% (w/v) dextran sulphate,
1 μg ml-1 denatured DIG-labelled antisense or sense RNA
probe for mouse SEC63 mRNA) at 55°C for 16 h. After
hybridization, the sections were washed in 50% forma-
mide/5 × SSC at 55°C for 15 min, 50% formamide/2 ×
SSC at 55°C for 30 min, 50% formamide/0.2 × SSC at
55°C twice for 30 min each, 0.2 × SSC at room tempera-
ture for 5 min and buffer I (100 mM Tris-HCl, pH 7.5, 150
mM NaCl) for 5 min. After non-specific binding was
blocked in 1% block mix (Boehringer Mannheim) in
buffer I for 1 h, sections were incubated in sheep anti-DIG
antibody conjugated with alkaline phosphatase (1:5000,
Boehringer Mannheim) in 1% block mix at 4°C over-
night. The signal was visualized with 0.4 mM BCIP/NBT
in the buffer III (100 mM Tris-HCl, pH 9.5, 100 mM NaCl
and 50 mM MgCl2). Endogenous alkaline phosphatase
activity was inhibited with 2 mM levamisole (Sigma). All
of the sections were counterstained with 1% (w/v) methyl
green, in 0.12 M glacial acetic acid and 0.08 M sodium
acetate, for 30 min. The positive signal was visualized as a
dark-brown color.
Immunohistochemistry
Mouse tissues
Immediately after mice were killed by cervical dislocation,
mouse uterine tissues were cut into 4–6 mm long pieces,
fixed in Bouin's solutions for 24 h, dehydrated and
embedded in paraffin (Beijing Chemical Co., Beijing,
China). Sections (7 μm) were cut, deparaffinized and
rehydrated. Nonspecific binding was blocked in 10% nor-
mal rabbit serum in PBS for 1 h at 37°C. Sections were
incubated with goat anti-sera specific for both mouse and
human Sec63 proteins (1:100, Santa Cruz Biotechnology
Inc) overnight at 4°C. After washing in PBS three times,
sections were incubated with biotinylated rabbit anti-goat
IgG (1:200, Vector Laboratories, Burlingame, CA, USA),
followed by an avidin-alkaline phosphatase (ALP) com-
plex and Vector red using the Vectastain ABC-AP kit (Vec-
tor Laboratories). Vector red was visualized as a red color.
Endogenous ALP activity was blocked by incubation with
2 mM levamisole (Sigma). Sections were counterstained
with hematoxylin (Sigma) and mounted. Negative con-
trols were performed by adding blocking peptides (8μg/
μg goat anti-Sec63 antibody) into the primary antibody
solution prior to addition of the solution to tissue sec-
tions.
Human tissues
The serial 6 μm-thick sections of human decidual and ovi-
ductal tissues, mounted on Poly-L-Lysine (Sigma) coated
glass slides, were incubated with 10% normal donkey
serum in PBST (PBS, pH7.4, containing 0.2% Tween-20)
for 1 h to block the nonspecific binding. Sec63 antigens
were recognized by goat anti-sera specific for both mouse
and human Sec63p (1:50, Santa Cruz Biotechnology Inc)
overnight at 4°C. After washing for 3 times in PBST, the
sections were incubated with biotin-conjugated donkey
anti-rabbit IgG (1:200, Abcam Plc, Cambridge, UK) for 1
hour at 37°C. After washing, strepavidin-HRP (Protein-
tech Group Inc, Chicago, IL) was added to bind with
biotin. DAB was used as substrate for the peroxidase reac-
tion. Sections were counterstained with hematoxylin,
dehydrated and mounted. As a control, the blocking pep-
tides neutralized antisera (8μg/μg goat anti-Sec63 anti-
body) was used at the same dilution.
Statistical analysis
The data were processed and the bar graphs were obtained
by SPSS13.0 (SPSS Inc., Chicago, IL). All the numerical
results are expressed as mean ± SE (standard error of
mean), and variances were analyzed for statistical signifi-
cance using one-way analysis of variance with p < 0.05.
The multiple comparisons were conducted with the Tukey
Method to analyze the differences of uterine SEC63
mRNA levels at days 4, 5 and 7 of pregnancy in real-time
quantitative PCR analysis.
Results
Tissue distribution of SEC63 mRNA
Multi-tissue RT-PCR analysis was performed to observe
the tissue distribution of the SEC63 gene expression in dif-
ferent mouse tissues using GAPDH as the housekeeping
control. The results showed that SEC63 mRNA was widely
expressed in all of the tissues tested (Fig. 1).
The tissue distribution of Sec63 mRNA in the mouse Figure 1
The tissue distribution of Sec63 mRNA in the mouse. 
The tissue distribution of Sec63 mRNA in the mouse was 
analyzed by RT-PCR by using Gapdh mRNA as the control. 
Sec63 mRNA was detected in all of the tested tissues. (B: 
brain; Lu: lung; H: heart; Li: liver; Sp: spleen; K: kidney; M: 
muscle; SI: small intestine; Sk: skin; T: testis; E: epididymis; O: 
ovary; U: uterus.)Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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Uterine expression level of SEC63 mRNA during peri-
implantation period
The uterine expression levels of SEC63 mRNA of days 4, 5
and 7 were determined by real-time quantitative PCR
analysis (See additional file 1 for Melting curve of real-
time quantitative PCR analysis for Sec63 mRNA). Com-
pared to that of day 4 pregnant mouse, the measured val-
ues of SEC63 mRNA in the mouse uterus on days 5 and 7
of pregnancy were significantly increased (Fig. 2A and
Table 1). Furthermore, the expression level of SEC63
mRNA was up-regulated in tendency at the implantation
sites compared to the inter-implantation sites on day 7
pregnancy (Fig. 2B), despite of the great variance possibly
resulting from the dissection operation of the implanta-
tion site and the non-implantation site.
Production of Sec63p in the mouse uterus during early 
pregnancy
The mouse Sec63p produced in the uterus during early
pregnancy was detected by Western blot. Sec63p was
detectable in the implantation sites on day 5 of preg-
nancy, and increased from day 6 to day 7 of pregnancy. In
addition, the Sec63 gene expression was up-regulated in
the implantation sites relative to that in the inter-implan-
tation sites on days 5–7 of pregnancy (Fig. 3).
In situ hybridization of SEC63 mRNA in the mouse uterus 
during early pregnancy
The expression of SEC63 mRNA in the uterus during the
peri-implantation period was examined by in situ hybrid-
ization. Only weak signals were detected in the epithelial
cells of uterine lumen and glands on day 1 (Fig. 4A), days
2–3 (data not shown) and day 4 (Fig. 4B). However, from
days 5 to 8 of pregnancy, more intense SEC63  mRNA
expression was predominantly observed in decidual cells
around the implanted embryo at the implantation site
(Fig. 4C, D, E), whereas expression at the inter-implanta-
tion site was dramatically reduced (Fig. 4H). In pseudo-
pregnant mice, weak Sec63 expression were observed in
the epithelial cells of uterine lumen and glands on day 5
(Fig 4G). Under delayed implantation, there was no
intense detection of Sec63 mRNA in the uterus (Fig 4I),
whereas intense Sec63 expression was mainly localized in
the decidualization area at the implantation site after the
activation of embryo implantation (Fig 4J).
Uterine expression pattern of Sec63p during early 
pregnancy in mice
Immunohistochemistry was conducted to determine
whether Sec63p was present in the mouse uterus. Only
weak immunostaining of Sec63p was detected in the epi-
thelial cells of uterine lumen and glands on day 1 (Fig.
5A), days 2–3 (data not shown) and day 4 (Fig. 5B).
Strong immunostaining of Sec63p was observed in the
epithelial cells and decidualized area around the
implanted embryo at the implantation site on days 5, 6
and 8 of pregnancy (Fig. 5C, D, F), whereas the staining
intensity at the inter-implantation site was sharply
decreased (data not shown). Furthermore, intense stain-
ing of Sec63p was also discerned in the ectoplacental cone
at the implantation site on day 8 (Fig. 5F). In pseudopreg-
nant mice, faint staining of Sec63p was observed in the
epithelial cells of uterine lumen and glands on day5 (Fig
5G). Similarly, some weak Sec63p staining was detected
in the epithelial cells of uterine lumen and glands under
delayed implantation (Fig. 5H), but more intense Sec63p
Uterine expression level of Sec63 mRNA during the early pregnancy Figure 2
Uterine expression level of Sec63 mRNA during the early pregnancy. Real-time quantitative PCR analysis of the 
expression level of Sec63 mRNA in mouse uterine tissues of day 4 (4), day 5 (5) and day 7 (7) pregnancy (panel A), as well as 
the inter-implantation sites (nI), implantation sites (I) and embryo (Em) of day 7 pregnancy (panel B), by using the β-Actin as the 
housekeeping gene. In panel A and panel B, the data were normalized relative to that of day 4 and nI (reference groups) respec-
tively.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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staining was localized in the decidualized area, as well as
in the epithelial cells of uterine lumen and glands, at the
implantation site after the activation of embryo implanta-
tion (Fig. 5I).
Expression of Sec63p in human decidual and oviductal 
tissues
The production of Sec63p in the human uterine and ovi-
ductal tissues was also determined by immunohistochem-
istry using the goat anti-sera specific for both mouse and
human Sec63p. Intense Sec63p staining signals were
observed in decidualized cells of uterine and oviductal tis-
sues (Fig. 6A, C); whereas the staining was faintly detected
in the gland epithelial cells of human endometrium at
proliferative (Fig. 6D) and secretory phase of the men-
strual cycle (Fig. 6E).
Discussion
Decidualization, characterized by growth and differentia-
tion of endometrial stromal cells, is a critical event
occurred during embryo implantation. In the present
study, we identified the predominant expression of SEC63
mRNA and Sec63p in the decidualized area of uterine tis-
sues during early pregnancy in mice. More interestingly,
an increased expression of Sec63p was also observed in
human decidualized uterine and oviductal tissues.
During the pregnancy, the fetomaternal interface, consist-
ing of the maternal decidua and the invading fetal tro-
phoblast, critically regulates placental function and the
growth and development of the conceptus. The maternal
decidua is differentiated from the endometrial tissues dur-
ing decidualization, a postovulatory process of endome-
trial remodeling in preparation for pregnancy [26,27]. In
most species studied, during the embryo implantation
process, an increase of endometrial vascular permeability
in areas adjacent to the blastocysts is the earliest macro-
scopically identifiable change, and, this is followed in spe-
cies with invasive implantation by decidualization
[28,29]. Meanwhile, molecules produced by endometrial
Table 1: Uterine Sec63 mRNA levels of days 4, 5 and 7 pregnant mice determined by real-time quantitative PCR
95% Confidence Interval
(I) Sample (J) Sample Mean Difference (I-J) Std. Error Sig. Lower Bound Upper Bound
Day 4 Day 5 -2.66558* .72340 .024* -4.8852 -.4460
Day 7 -2.70786 * .72340 .022* -4.9275 -.4883
Day 5 Day 4 2.66558 * .72340 .024* .4460 4.8852
Day 7 -.04228 .72340 .998 -2.2619 2.1773
Day 7 Day 4 2.70786* .72340 .022* .4883 4.9275
Day 5 .04228 .72340 .998 -2.1773 2.2619
(*: the mean difference is significant at the .05 level)
Uterine expression level of SEC63 protein during the early pregnancy Figure 3
Uterine expression level of SEC63 protein during the early pregnancy. Western blot analysis of SEC63 expressed in 
mouse uterine tissues during the early pregnancy using the goat anti-sera specific for both mouse and human Sec63p (1:50) as 
the primary antibody. Total protein (100 μg) was exacted from uteri of day 1 (D1) and day 4 (D4) pregnant mice, and from 
inter-implantation sites (i-I) and implantation sites (I) on day 5 (D5) and day 6 (D6). On day 7 (D7), embryos (e) were also sep-
arated from the implantation sites. Panel A shows the SEC63 signal detected by goat anti-sera specific for both mouse and 
human Sec63p. Panel B shows the equal of loading samples stained by the rabbit anti-β-actin antibody.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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epithelium, including cytokines, chemokines, growth fac-
tors, and proteinases, could be secreted into the uterine
lumen to affect blastocyst development, migration, and
attachment, or to basally facilitate the differentiation of
the underlying stromal cells to produce decidual cells; and
these decidual cells, which subsequently form a major
component of the decidua of pregnancy, also produce a
set of secreted proteins, such as insulin-like growth factor
binding protein-1 (IGFBP1) [30] and placental protein 14
(PP14) [31], to drive the decidualization process [2,32].
Therefore, the process of decidualization is accompanied
by the frequent production and secretion of a number of
secretary proteins in endometrial tissues which fills the
intrauterine cavity and glandular lumen [33].
The targeting and transport of precursors of secretary pro-
teins into the endoplasmic reticulum (ER) is essentially
required for the biosynthesis of most secretory proteins
[10,34], and the protein translocation channel in the ER
membrane mediates such a transport [11]. Specific pro-
tein complexes that recognize the signal sequence of these
precursors are involved in their translocation to the mem-
brane of the ER [10]. However, different translocation
substrates appear to have different requirements for com-
ponents of the cellular targeting and translocation
machinery [35]. The major components of translocation
machinery are signal recognition particle (SRP) and secre-
tory (Sec) complex [36]. The later consists of Sec61p,
Sec62p, Sec63p, Sec71p and Sec72p[10,18]. However,
being different from the other Sec complex components,
Sec63 is also involved in the SRP-dependent transport
pathway [13]. Dysfunction of the SEC63 gene is associ-
ated with defects in protein translocation into the ER[37]
and results in human diseases including various cancers
[29] and the polycystic liver disease (PCLD) [12,38].
The precise bio-functions of Sec63p in mammals, espe-
cially the role it plays in reproduction, are still unclear.
The group of secretary proteins of which precursors are
targeted by Sec63p has not yet been identified in mam-
Determination of uterine Sec63 mRNA in the mouse by in situ hybridization analysis Figure 4
Determination of uterine Sec63 mRNA in the mouse by in situ hybridization analysis. In situ hybridization of Sec63 
mRNA was performed using digoxigenin-labeled anti-sense probes generated against Sec63 cDNA in the mouse uterus on day 
1(A) and day 4 (B) of pregnancy; at the implantation site of day 5(C), day 6 (D) and day 8 (E); at the inter-implantation site of 
day 6 (H); in the uterus of day 5 pseudopregnant mouse (G); delayed implantation (I) before and (J) after activation. (F) is the 
same as (E), but sense sequence was used for substitution as control. L: lumen of uterus; G: gland; SC: stromal cells; DC: decid-
ual cells; EM: embryo. Scale bars represents 50 μm.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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mals. However, it has been demonstrated in yeast that,
Sec63p is involved in post-translational translocation of
invertase, CPY and DPAP B [15,20,21]. Invertase, encoded
by SUC2, is a sucrose hydrolyzing enzyme that cleaves
sucrose into the glucose, and therefore plays a central role
in carbohydrate metabolism [39]. Carbohydrate metabo-
lism controls the mammalian development during the
pre- and peri-implantation period [40,41], and the abnor-
mal glucose level in uterus disrupts cell apoptosis during
embryonic development[41]. CPY is a yeast vacuolar ser-
ine protease with structural homology to Cathepsin A in
mammals. Cathepsin A is involved in the C-terminal
processing of some implantation-related peptides/pro-
teins including endothelin, substance P, and bradykinin
[42]. Deficiency of cathepsin A leads to the lysosomal
storage disease, galactosialidosis, in human [43]. DPAP B,
another membrane protein of the yeast vacuole, is signif-
icantly homologous to mammalian dipeptidyl peptidase
IV (DPP IV) [44]. Active DPP IV is present in glandular
cells and surface epithelium during the peri-implantation
period, and regarded as a differentiation marker for glan-
dular cells; however, DPP IV enzyme activity is not
detected in endometrial stromal and decidual cells
throughout the menstrual cycle or during early pregnancy
[45].
In addition, mutations in SEC63 leads to an autosomal
dominant disease resulted from defects in protein
Examination of uterine SEC63 protein in the mouse by Immunohistochemical staining Figure 5
Examination of uterine SEC63 protein in the mouse by Immunohistochemical staining. SEC63p immunohisto-
chemical staining of mouse uterine tissues was performed by using goat anti-sera specific for both mouse and human Sec63p as 
the primary antibody. The uterine sections were stained with Sec63 for day 1 (A) and day 4 (B) pregnant uterus; the implanta-
tion site of day 5 (C), day 6 (D) and day 8 (F); day 5 pseudopregnant uterus (G); and delayed implantation before (H) and 24 hr 
after activation (I). Panel E is the negative control for panel B, in which normal goat serum is substituted for the primary anti-
body. L: lumen of uterus; G: gland; SC: stromal cells; DC: decidual cells; EM: embryo. Scale bars represents 10 μm.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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processing, PCLD [38]. Most recently, it has been reported
that, the expression of cell adhesion molecules, E-cad-
herin and Ep-CAM (epithelial cell adhesion molecule),
were remarkably decreased in liver tissue of PCLD [46].
This suggests that, Sec63p might directly or indirectly reg-
ulate the secretion of these cell adhesion molecules. Cell
adhesion molecules including integrins, selectins, and
cadherins are crucial required for the successful interac-
tion between embryo and endometrium. More interest-
ingly, being similar to Sec63p in uterine expression
pattern, a high level of E-cadherin expression was also
detected specifically at the implantation sites in the
endometrium of peri-implantation uterus[47]. Ep-CAM is
a glycoprotein presented on most carcinomas, and has
positive effects on the epithelial cell proliferation [48].
But, the expression pattern of Ep-CAM in uterus is still
needed to be investigated. Based on above mentioned
clues, we speculated that, during the process of deciduzli-
zation, the intracellular expression of Sec63p is up-regu-
lated and subsequently accelerate the decidualizing
stromal cells and decidual cells to secret molecules
involved in the regulation of cell growth or/and cell adhe-
sion during the formation of deciduas.
Furthermore, in present study, a strong staining of Sec63p
at the ectoplacental cone on day 8 of pregnancy was also
detected. It has been well understood that, local deciduo-
placental autocrine-paracrine regulation is essential for
the maintenance of pregnancy, and the expression of
numerous secretary proteins at the ectoplacental cone
have been reported in mice. Selenoprotein P (Sepp), an
extracellular glycoprotein, is a selenium transporter and
antioxidant. SEPP mRNA was detected principally in the
ectoplacental cone since embryonic day 7.5 in mice [49].
Detectable amounts of IL-18 were seen in the basal prolif-
erative stroma in the peri-implantation period, and a high
level of IL-18 expression was observed in the ectoplacental
cone in the immediate post-implantation period [50].
Thus, Sec63p might play important roles not only in
embryo implantation, in particular in decidualization,
but also in early placentation in mice.
Collectively, we demonstrated the abundant expression of
SEC63 gene in the mouse and human decidualized cells
during early pregnancy in this study. This is consistent
with the transformation of uterine stromal cells into secre-
tory decidual cells during the process of decidualization.
The present of SEC63 in human tissues detected by IHC analysis Figure 6
The present of SEC63 in human tissues detected by IHC analysis. Immunohistochemical staining for SEC63 in human 
decidua of 10-week pregnancy (A), human oviduct of 10-week ectopic pregnancy (C), human endometrium at proliferative 
phase (D) and human endometrium at secretory phase (E) by using goat anti-sera specific for both mouse and human Sec63p as 
the primary antibody. Panel B and F are the negative controls respectively for panel A and C, in which normal goat serum is 
substituted for the primary antibody. Scale bars represents 50 μm.Reproductive Biology and Endocrinology 2009, 7:12 http://www.rbej.com/content/7/1/12
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Furthermore, the confirmation of uterine expression of
Sec63 in the human tissues further strengthens the rele-
vance of the mouse-derived data to the situation of
human pregnancy. However, further studies are required
to determine the exact function of Sec63p in the uterus
and the significance of its up-regulated expression at the
implantation site.
Conclusion
Taken together, our results indicated that uterine SEC63
gene expression is up-regulated at the implantation sites
during the early pregnancy, consistent with a possible role
in regulating the production of some secretory proteins
during embryo implantation, especially at the stage of
decidualization.
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